Evaluation of drugs for the treatment of gastroesophageal reflux disease (GORD)

  • Email
  • Help
Current effective version

Adopted guideline

Reference numberCHMP/EWP/342691/09
Effective from01/10/2011
KeywordsGastro-oesophageal reflux disease (GORD), reflux oesophagitis, non-erosive reflux disease (NERD)
DescriptionThis document addresses the European regulatory position on the development of products for the treatment of gastro-oesophageal reflux disease in adults and children.

Document history

First version 

Current version

Adopted guideline

Overview of comments

Draft guideline

Concept paper

In operation: 01/10/2011–present

Published: 14/03/2011

Published: 08/01/2010

Published: 19/02/2009

Related content

How helpful is this page?

Average rating:

 Based on 15 ratings

Add your rating:

See all ratings
3 ratings
3 ratings
3 ratings
3 ratings
3 ratings

Tell us more